Scientists Discover How Evening Scrolling Is Linked to Insomnia

💡 Key Finding: The problem isn’t just the blue light — it’s the emotional content and the habitual nature of scrolling that keeps the brain aroused and delays sleep.

📌 Key Insight: Scrolling social media before bed doesn’t just delay sleep — it reduces sleep quality and shortens overall rest time, even if you eventually get into bed at a reasonable hour.

Dayvigo contains Lemborexant, a dual orexin receptor antagonist (DORA) that helps regulate the sleep-wake cycle. Unlike traditional sleep medications, it selectively targets wake-promoting orexin receptors, allowing for more natural sleep architecture with a lower risk of dependence.

Available in 5 mg and 10 mg strengths, Dayvigo is indicated for chronic insomnia, helping patients fall asleep faster and stay asleep longer.

💊 Learn More About Dayvigo

⚠️ Important: Dayvigo is a prescription medication and should only be used under medical supervision. It is not a substitute for healthy sleep hygiene practices. Always consult a healthcare provider before starting any new medication.

Does blue light from screens cause insomnia?

The Norwegian study found that the issue is not just about blue light. While blue light can suppress melatonin, the emotional content and habitual nature of scrolling are equally important factors that keep the brain aroused and delay sleep.

How much does evening screen use affect sleep?

Each additional hour of screen use after getting into bed increases insomnia risk by 59% and reduces total sleep by approximately 24 minutes.

What is Dayvigo and how does it work?

Dayvigo (Lemborexant) is a dual orexin receptor antagonist that regulates the sleep-wake cycle by blocking wake-promoting signals in the brain. It helps patients fall asleep faster and stay asleep longer.

Can lifestyle changes fix insomnia?

For many people, healthy sleep hygiene — including reducing screen time before bed, creating a relaxing bedtime routine, and keeping devices out of the bedroom — can significantly improve sleep. However, chronic insomnia may require professional evaluation and treatment.

Who conducted this research?

The study was conducted by scientists from the Norwegian Institute of Public Health in collaboration with the University of Bergen, analyzing data from over 45,000 students.

⚠️ Medical Disclaimer

This content is for informational and educational purposes only. Insomnia is a medical condition that should be evaluated by qualified healthcare professionals. Dayvigo (Lemborexant) is a prescription medication and should only be used under the supervision of a healthcare provider. Lifestyle changes should be discussed with your doctor.

© 2026 BuyAllMD.com — Evidence-Based Sleep Health & Public Health News